Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Predicting risk of progressive multifocal leukoencephalopathy from natalizumab.

Predicting risk of progressive multifocal leukoencephalopathy from natalizumab. N Engl J Med. 2012 May 17; 366(20):1938-9.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.